Recently, the search frequency for Isu Abxis, known as a company under the Isu Group affiliate that develops antibiotic treatments and provides medical services, has surged.
As of 11:30 AM on the 24th, Isu Abxis's stock price is 8,900 KRW, down 7.29% from the previous day, with a trading volume of 2,241,981 shares, which is about 28.76% of the 5-day average trading volume. Foreign investors are tentatively reported to have net purchased 4,000 shares today.
On February 23rd, Isu Abxis was a market topic with the headline "Rising trend due to agreement on producing Russian COVID-19 vaccine."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
